myoscience, inc. reveals the addition of Peter Osborne to the team as chief financial officer. Osborne has over 25 years of experience in high growth public and private companies, most notably with Hansen Medical, VNUS Medical Technologies, and SentreHEART, Inc.
New Advances in Treating Hyperpigmentation
This past decade has seen an enormous surge in popularity of skin brightening products formulated specifically to treat hyperpigmentation and…

0 Comments